Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03125642 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Auto Stem Cell Transplant for Lymphoma Patients

StatusRecruiting
PhasePhase 2
Started2017-04-20
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 4, 2025 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2025-10-31
Study Status v12
Primary completion date2025-09-30→2026-09-30
Completion date2026-04-30→2027-04-30
2024-11-01
Study Status v11
Re-verified, no change to tracked fields
2023-11-01
Study Status v10
Primary completion date2023-09-30→2025-09-30
2023-06-02
Study Status v9
Primary completion date2023-04-30→2023-09-30
2023-01-25
7 amendments v2-v8
7 re-verifications since 2017-10-04, no change to tracked fields
2017-04-24
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2017-04-26→confirmed 2017-04-20
Study sitesdetails revised at 1 of 1 site
2017-04-19
Original filing
This is a phase II study of autologous transplant for patients with Hodgkin (HL) and non-Hodgkin lymphomas (NHL) including those who are HIV positive.
Trial Details
NCT Number NCT03125642
Lead Sponsor Masonic Cancer Center, University of Minnesota
Conditions Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Enrollment 150 participants
Start Date 2017-04-20
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-04